Fandom

Psychology Wiki

Genetic counseling: Fanconi Anemia

34,203pages on
this wiki
Add New Page
Talk0 Share

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Clinical: Approaches · Group therapy · Techniques · Types of problem · Areas of specialism · Taxonomies · Therapeutic issues · Modes of delivery · Model translation project · Personal experiences ·


Fanconi Anemia

OverviewEdit

  • Inherited anemia leading to bone marrow failure (aplastic anemia) and myelodysplasia (5%) or acute myelogenous leukemia (10%) and physical abnormalities (60-75%), and increased risk for other cancers

Associated CancersEdit

  • Acute myelogenous leukemia
  • Older patients risk of head and neck, esophageal, gastrointestinal, and genital tract cancers
    • Usually develop after 13 years of age (average age is 23)
    • Difficult to treat due to sensitivity to DNA-damaging agents such a chemo and radiation
  • Patients who receive androgen treatment are at increased risk of liver tumors

Physical Characteristics/symptomsEdit

(25-40% have no physical abnormalities)

  • Short stature (60%)
  • Extreme fatigue
  • Frequent infections
  • Nosebleeds or easy bruising
  • Low white cell, red cell, or platelet count (age of onset highly variable)
  • Myelodysplasia
  • Upper limb malformations: misshapen, missing or extra thumbs or an incompletely developed or missing radius (50%)
  • Other skeletal anomalies (30%) - short low hairline, spina bifida, scoliosis, sacrococcygeal sinus, vertebral anomalies
  • Renal malformations (25%) pelvic, horseshoe, hypoplastic, dysplastic kidney or abnormal artery or abnormal collecting system
  • Abnormal skin pigmentation (café-au-lait spots, hyperpigmentation, hypopigmentation (65%)
  • Microcephaly
  • Eyes (25%) - micropthalmia, strabismus, epicanthal folds, hypertelorism/hypotelorism, ptosis, slanting, cataracts, epiphora, nystagmus
  • Genitalia (40%) -
    • males: hypogenitalia, undescended, absent or atrophic testes, azospermia, delayed puberty. Few males have fathered children
    • females: hypogenitalia, bicornauate uterus, absence of uterus or vagina, ovarian atresia, delayed menarche, irregular menses, early menopause. Successful pregnancies have been reported
  • Ears (10%) - deafness usually conductive due to middle ear anomalies, abnormal pinna, stenosis or atreasia of external auditory meatus, lowest, large or small ears
  • Heart structural defects, cardiomyopathy
  • Lower limbs-toe syndactyly, pes planus, abnormal toes, congenital hip dislocation
  • Mental retardation or learning disabilities
  • Low birth weight
  • Gastrointestinal problems/malformations

Genetic BasisEdit

  • AR inheritance
  • At least 8 FA genes A (16q24.3) 66%, B(?) 4%, C(9q22.3) 12%, D1 rare, D2(3p25.3) rare, E(6p21-22) 12%, F(11p15) rare, G(9p13) rare, (BRCA2 is thought to be B or D1)
  • FA-A and FA-C mutations account for 76% of patients
  • FA pathway regulates DNA repair

IncidenceEdit

  • Found equally in males and females
  • All ethnic groups
  • 1 in 100,000 live births

Carrier frequencyEdit

  • Estimated between 1 in 600 and 1 in 100
  • gene clinics states 1 in 300 for general population in US, Europe and Japan
  • AJ frequency is 1 in 89

Diagnosis and testingEdit

  • Chromosomal breakage studies in presence of diepoxybutane (DEB) or mitomycin C (MMC)
  • Only FA cells exhibit increased chromosomal breakage in response to DEB
  • Chromosomal breakage can be performed prenatally with cells from CVS or amnio
  • If mutations known, mutation analysis can be performed prenatally
  • Chromosome breakage tests don't detect carriers
  • Siblings should be tested since 25-40% of individuals with FA may have no physical abnormalities
  • Complementation studies and mutation analysis available for 6 of the genes on research basis
  • Fanconi Anemia mutation database found at www.rockefeller.edu/fanconi/mutate/
  • FA cell repository in Oregon (will do complementation analysis)
  • Carrier testing available once mutations identified

MosaicismEdit

  • Some cells revert to normal phenotype
  • Attributed to recombination or gene conversion
  • May cause false negative DEB test

Geneotype-PhenotypeEdit

  • Appear to be some correlations

Differential DiagnosisEdit

  • Bloom syndrome, ataxia telangiectasia, and other chromosomal breakage syndromes are all ruled out by DEB chromosomal breakage test
  • NF1 shares café au lait spots
  • Thrombocytopenia with absent radii
  • VACTERL syndrome
  • Above are ruled out by DEB or MMC test

LeukemiaEdit

  • Malignancy where bone marrow produces excess quantities of immature white cells called blasts
  • These suppress the development of healthy blood cells
  • Results in infections and bleeding
  • AML is a particularly aggressive type usually found in older people

Management of FAEdit

(focuses on surveillance of and treatment for physical abnormalities, bone marrow failure, and related cancers)

  • Baseline tests
    • Ultrasound of kidneys and urinary tract
    • Formal hearing test
    • Baseline developmental assessment
    • Referral to ophthalmologist, endocrinologist, and geneticist for initial screening and counseling
    • Follow by hematologist
      • HLA typing of patient, sibs, and parents: full blood typing and blood chemistries
      • Regular blood counts
      • Many recommend annual bone marrow aspirate or biopsy to evaluate morphology, cellularity, and cytogenetics
  • Androgens
    • Improve blood counts in ~50% of patients
    • stimulate production of RBC's, often platelets, sometimes WBC's
    • patients often eventually fail to respond to this treatment
  • Hematopoetic growth factors
    • G-CSF or GM-CSF stimulate production of WBC's in some patients
    • Improved platelet and red cell count in a few patients
    • Generally not recommended for patients with a clonal cytogenetic abnormality
  • Blood transfusions
    • Should be avoided or minimized if patient is a candidate for bone marrow transplantation
    • Family members should be avoided as blood donors to minimize chance of sensitization if considering bone marrow transplant
  • Bone marrow transplant
    • Only long-term cure for blood problems
    • Many associated risks
  • Gene therapy
    • Clinical trials for patients with mutations in A or C gene
    • Potentially correct the hematopoietic defect, but not reduce the risk of developing solid tumors in other tissues
    • Not done if considering bone marrow transplant

ResourcesEdit

  • Fanconi Anemia Cell Repository
Department of Medical and Molecular Genetics
Oregon Health & Science University
3181 SW Sam Jackson Park Rd, L103
Portland, OR 97201
Phone: 503-494-6888
  • Fanconi Anemia Research Fund, Inc (FARF)
1801 Willamette Street, Suite 200
Eugene, OR 97401
Phone: 800-828-4891; 541-687-4658
Fax: 541-687-0548
Email: info@fanconi.org
www.fanconi.org
  • Fanconi Anemia Mutation Registry
www.rockefeller.edu/fanconi/mutate
  • Cancer Fund of America
2901 Breezewood Lane, Knoxville, TN 37921-1009
(423) 938-5281
Supplies and financial aid for low income
cancer patients
  • For more resources see Fanconi Anemia: A Handbook for Families and Their Physicians, 2000

ReferencesEdit

  • Gene Reviews www.geneclinics.com Fanconi anemia
  • Handout from presentation by Dr. Alan D'Andrea
  • Lynn and Dave Frohnmayer. Fanconi Anemia: A Handbook for Families and Their Physicians Third Edition, 2000
  • "Biallelic Inactivation of BRCA2 in Fanconi Anemia" was published in the June 13, 2002 edition of Sciencexpress, one of the on-line versions of the journal Science.
  • Fanconi Anemia Research Fund www.fanconi.org

NotesEdit

The information in this outline was last updated in 2003.



This material has been imported fom the wikibook "Genetic counseling"[ http://en.wikibooks.org/wiki/Genetic_counseling] under the GNU Free Documentation License.

Heckert GNU white Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled "GNU Free Documentation License."

Ad blocker interference detected!


Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.

Also on Fandom

Random Wiki